Morgan Younkin

HIV Pre- and Post-Exposure Prophylaxis Prescribing for Hospitalized People who Inject Drugs Cared for by an Addiction Consult Service

Paul J. Christine, Hallie Rozansky, Morgan Younkin, Jason M. Fox et autres

us (code pays fourni par la source)

Addiction consult service involvement in PrEP and PEP delivery for patients who inject drugs admitted to an urban essential hospital

Hallie Rozansky, Paul J. Christine, Morgan Younkin, Jason M. Fox et autres

BACKGROUND: Addiction medicine providers have a key role in HIV prevention amidst rising HIV incidence in persons who inject drugs (PWID). Pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) are vastly underutilized in this population. Inpatient hospitalization represents a potential touchpoint for initiation …

us (code pays fourni par la source)

Treating Benzodiazepine Withdrawal in a Bridge Clinic

Jordana Laks, Theresa W. Kim, Paul J. Christine, James C. Evans et autres

BACKGROUND: Benzodiazepine-involved overdose deaths are rising, driven by increasing use of nonprescribed benzodiazepine pills. For patients who wish to stop nonprescribed benzodiazepine use, rapid inpatient tapers are typically the only option to treat benzodiazepine withdrawal. Substance use disorder bridge clinics can provide …

us (code pays fourni par la source)

Addressing Substance Use Disorders in People Experiencing Homelessness.

Morgan Younkin, Rebecca Lee, Paula Hercule

The End of the X-waiver: Excitement, Apprehension, and Opportunity

Nicholas M. LeFevre, Joshua St. Louis, Emma Worringer, Morgan Younkin et autres

With the passage of the MAT act (Mainstreaming Addiction Treatment) and the MATE Act (Medication Training and Expansion), the Drug Enforcement Agency "X-waiver" program governing the office-based prescription of buprenorphine for opioid use disorder has been immediately eliminated. The move was championed …

us (code pays fourni par la source)

HIV treatment failure; ART toxicity & complications

Morgan Younkin

This is Session 2 in the PEER Liberia HIV/Viral Hepatitis Lecture Series. This presentation provides an overview of HIV antiretroviral therapy, treatment monitoring, failure and complications.

Overview & History of HIV: Epidemiology, ART, 1st line treatment & monitoring

Morgan Younkin

This is Session 1 in the PEER Liberia HIV/Viral Hepatitis Lecture Series. This presentation provides an overview and history of HIV, including epidemiology, testing, treatment and monitoring.

Focused Review of Antiretroviral Treatment

Morgan Younkin

This presentation is a review of Sessions 1 and 2 in the PEER Liberia HIV/Viral Hepatitis Lecture Series and provides an overview of HIV antiretroviral therapy and complications.

Opportunistic Infections, & Hepatitis B treatment & monitoring

Morgan Younkin

This is Session 3 in the PEER Liberia HIV/Viral Hepatitis Lecture Series. This presentation provides an overview of HIV opportunistic infections and Hepatitis B treatment and monitoring.

Characteristics of Fentanyl Overdose — Massachusetts, 2014–2016

Nicholas J. Somerville, Julie K. O’Donnell, R. Matthew Gladden, Jon E. Zibbell et autres

Opioid overdose deaths in Massachusetts increased 150% from 2012 to 2015 (1). The proportion of opioid overdose deaths in the state involving fentanyl, a synthetic, short-acting opioid with 50-100 times the potency of morphine, increased from 32% during 2013-2014 to 74% in …

us (code pays fourni par la source)

A single-institution review of 157 patients presenting with benign and malignant tumors of the ampulla of Vater: Management and outcomes

John R. Hornick, Fabian Mc. Johnston, Peter O. Simon, Morgan Younkin et autres

us (code pays fourni par la source)

Localized Ampullary Cancers (T1) Are Best Treated With Pancreaticoduodenectomy

John R. Hornick, Peter O. Simon, Morgan Younkin, Fabian Mc. Johnston et autres

us (code pays fourni par la source)